Wakamatsu Yuji
,
Murakami Masato
,
Takami Mitsuru
,
Kimura Masaomi
,
Fukaya Hidehira
,
Nakahara Shiro
,
Kato Takeshi
,
Hayashi Hiroshi
,
Iwasaki Yu-ki
,
Shimizu Wataru
,
Nakajima Ikutaro
,
Nagashima Koichi
,
Harada Tomoo
,
Koyama Junjiroh
,
Okumura Ken
,
Tokuda Michifumi
,
Yamane Teiichi
,
Tanimoto Kojiro
,
Momiyama Yukihiko
,
Nonoguchi Noriko
,
Soejima Kyoko
,
Ejima Koichiro
,
Watanabe Ryuta
,
Hagiwara Nobuhisa
,
Harada Masahide
,
Sonoda Kazumasa
,
Inoue Masaru
,
Kumagai Koji
,
Hayashi Hidemori
,
Yazaki Yoshinao
,
Satomi Kazuhiro
,
Watari Yuji
,
Okumura Yasuo
,
Arai Masaru
,
Yokoyama Katsuaki
,
Matsumoto Naoya
,
Otsuka Takayuki
,
Suzuki Shinya
,
Hirata Akio
… The study patients were classified as 749 (64.4%) appropriate standard-dose DOAC users, 216 (18.6%) off-label under-dose DOAC users, and 198 (17.0%) appropriate low-dose DOAC users.</p><p>Age and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores differed significantly between DOAC dosing regimens, with patients given an appropriate standard-dose being significantly younger (63.3 ± 9.4 versus 64.8 ± 9.5 versus 73.2 ± 6.8 years, <i>P</i> …
J-STAGE